Evaluation of the new cesium-131 seed for use in low-energy x-ray brachytherapy

Medical Physics

Volumn 31, Issue 6, 2004, Pages 1529-1538

  Murphy, Mark K ^a   Piper, R Kim ^a   Greenwood, Lawrence R ^a   Mitch, Michael G ^b   Lamperti, Paul J ^b   Seltzer, Stephen M ^b   Bales, Matt J ^c   Phillips, Mark H ^c  

^a PACIFIC NORTHWEST NATIONAL LABORATORY   (United States)

^b NATIONAL INSTITUTE OF STANDARDS AND TECHNOLOGY   (United States)

^c UNIVERSITY OF WASHINGTON   (United States)

Author keywords

Air kerma strength; Anisotropy function; Brachytherapy; Brachytherapy seed; Cesium 131; Dose rate constant; Dosimetry; Monte Carlo; Radial dose function; TG 43; Thermoluminescent dosimetry

Indexed keywords

ANISOTROPY; CESIUM; DOSIMETRY; MONTE CARLO METHODS; ONCOLOGY; RADIOTHERAPY; RATE CONSTANTS; X RAYS;

AIR KERMA; BRACHYTHERAPY; DOSE RATE CONSTANTS; RADIAL DOSE FUNCTION; TG-43; THERMOLUMINESCENT DOSIMETRY;

FUNCTION EVALUATION;

CESIUM; CESIUM 131; RADIOISOTOPE; UNCLASSIFIED DRUG;

AIR; ANISOTROPY; ARTICLE; BRACHYTHERAPY; BRACHYTHERAPY SEED; DOSIMETRY; ENERGY; HALF LIFE TIME; MONTE CARLO METHOD; PRIORITY JOURNAL; RADIATION DOSE; THERMOLUMINESCENCE DOSIMETER; X RAY;

EID: 3042645234     PISSN: 00942405     EISSN: None     Source Type: Journal    
DOI: 10.1118/1.1755182     Document Type: Article

References (38)

1. U. K. Henschke and D. C. Lawrence, "Cesium-131 seeds for permanent implants," Radiology 85, 1117-1119 (1965).
2. R. G. Dale, "Radiobiological assessment of permanent implants using tumour re-population factors in the linear-quadratic model," Br. J. Radiol. 62, 241-243 (1989).
3. R. G. Dale, "The application of the linear-quadratic dose-effect equation to fractionated and protracted radiotherapy," Br. J. Radiol. 58, 515-528 (1985).
4. C. I. Armpilia, R. G. Dale, I. P. Coles, B. Jones, and V. Antipas, "The determination of radiobiologically, optimized half-lives for radionuclides used in permanent brachytherapy implants," Int. J. Radiat. Oncol., Biol., Phys. 55, 378-385 (2003).
5. D. J. Brenner, A. A. Martinez, G. K. Edmundson, C. Mitchell, H. D. Thames, and E. P. Armour, "Direct evidence that prostate tumors show high sensitivity to fractionation (low α/β ratio) similar to late responding normal tissue," Int. J. Radiat. Oncol., Biol., Phys. 52, 6-13 (2002).
6. D. J. Brenner and E. J. Hall, "Fractionation and protraction for radiotherapy of prostate carcinoma," Int. J. Radiat. Oncol., Biol., Phys. 43, 1095-1101 (1999).
7. R. Nath, L. L. Andersen, G. Luxton, K. A. Weaver, J. F. Williamson, and A. S. Meigooni, "Dosimetry of interstitial brachytherapy sources: Recommendations of the AAPM Radiation Therapy Committee Task Group No. 43," Med. Phys. 22, 209-233 (1995).
8. J. F. Williamson, B. M. Coursey, L. A. DeWerd, W. F. Hanson, and R. Nath, "Dosimetric prerequisites for routine clinical use of new low energy photon interstitial brachytherapy sources," Med. Phys. 25, 2269-2270 (1998).
9. R. Loevinger, "Wide-angle free-air chamber for calibration of low-energy brachytherapy sources (abstract)," Med. Phys. 20, 907 (1993).
10. E. E. Furhang and L. L. Anderson, "Functional fitting of interstitial brachytherapy dosimetry data recommended by the AAPM Radiation Therapy Committee Task Group 43," Med. Phys. 26, 153-160 (1998).
11. J. F. Briesmeister, in "MCNP-A general Monte Carlo N-particle transport code-Version 4C," Los Alamos National Laboratory Report LA-13709-M, March 2000.
12. J. J. DeMarco, G. Hugo, and T. D. Solberg, "Dosimetric parameters for three low-energy brachytherapy sources using the Monte Carlo N-Particle code," Med. Phys. 29, 662-668 (2002).
13. 125I source," Med. Phys. 28, 629-637 (2001).
14. H. E. Johns and J. R. Cunningham, The Physics of Radiology, 3rd ed. (Charles C. Thomas Publishing, Springfield, IL, 1974).
15. International Commission on Radiation Units (ICRU), "Radiation dosimetry-X rays and gamma rays with maximum photon energies between 0.6 and 50 MeV," ICRU Report 14, ICRU, Bethesda, MD, 1969.
16. International Commission on Radiation Units (ICRU), "Average energy required to produce an ion pair," ICRU Report 31, ICRU, Bethesda, MD, 1979.
17. J. R. Cameron, N. Suntharalingam, and G. N. Kenney, Thermoluminescent Dosimetry (The University of Wisconsin Press, Madison, 1968), Chap. 8.
18. S. W. S. McKeever, M. Moscovitch, and P. D. Townsend, Thermoluminescence Dosimetry Materials: Properties and Uses (Nuclear Technology Publishing, City, 1995), pp. 86-88.
19. J. H. Hubbell and S. M. Seltzer, "Tables of x-ray mass attenuation coefficients, and energy absorption coefficients from 1 keV to 20 MeV for elements z = 1 to 92 and 48 additional substances of dosimetric interest." NISTIR 5632, National Institute of Standards and Technology, Gaithersburg, MD, 1995.
20. International Organization for Standardization (ISO), "Guide to the expression of uncertainty in measurement," prepared by ISO Technical Advisory Group 4 (TAG 4), Working Group 3 (WG 3), October 1993.
21. J. F. Williamson, B. M. Coursey, L. A. Dewerd, W. F. Hanson, R. Nath, M. J. Rivard, and G. S. Ibbott, "On the use of apparent activity (App) for treatment planning of 1-125 and Pd-103 interstitial brachytherapy sources: Recommendations of the American Association of Physicist in Medicine Radiation Therapy Committee Subcommittee on low-energy brachytherapy source dosimetry," Med. Phys. 26, 2529-2530 (1999).
22. 125I sealed source dosimetry," IJROBP 40, 697-701 (1998).
23. G. Luxton and G. Jozsef, "Radial dose distribution, dose to water and dose rate constant for monoenergetic photon point sources from 10 keV to 2 MeV: EGS4 Monte Carlo model calculation," Med. Phys. 26, 2531-2538 (1999).
24. G. Luxton, "Comparison of radiation dosimetry in water and solid phantom materials from I-125 and Pd-103 brachytherapy sources: EGS4 Monte Carlo study," Med. Phys. 21, 631-641 (1994).
25. J. F. Williamson, H. Perera, and Z. Li, "Comparison of measured and calculated dose rates in water near I-125 and Ir-192 seeds," Med. Phys. 20, 209-222 (1993).
26. 125I brachytherapy source," Med. Phys. 27, 2168-2173 (2000).
27. C. C. Popescu, J. Wise, K. Sowards, A. S. Meigooni, and G. S. Ibbott, "Dosimetric characteristics of the Pharma Seed™ model BT-125-I source," Med. Phys. 27, 2174-2181 (2000).
28. 103Pd brachytherapy source," Med. Phys. 28, 2568-2575 (2001).
29. D. M. Duggan and B. L. Johnson, "Dosimetry of the I-Plant Model 3500 iodine-125 brachytherapy source," Med. Phys. 28, 661-670 (2001).
30. H. Hedtjam, G. A. Carlsson, and J. F. Williamson, "Monte Carlo-aided dosimetry of the symmetra* I-125, model 125.SO6 interstitial brachytherapy seed," Med. Phys. 27, 1076-1085 (2000).
31. B. H. Heintz, R. E. Wallace, and J. M. Hevezi, "Comparison of I-125 sources used for permanent interstitial implants," Med. Phys. 28, 671-682 (2001).
32. 125I interstitial brachytherapy source," Med. Phys. 28, 764-772 (2001).
33. R. E. Wallace and J. J. Fan, "Evaluation of a new brachytherapy iodine-125 source by AAPM TG-43 formalism," Med. Phys. 25, 2190-2196 (1998).
34. 103Pd brachytherapy source," Med. Phys. 27, 1093-1100 (2000).
35. 103palladium brachytherapy source," Med. Phys. 26, 2465-2470 (1999).
36. K. Weaver, "Anisotropy functions for I-125 and Pd-103 sources," Med. Phys. 25, 2271-2278 (1998).
37. C. M. Lederer and V. S. Shirley, Table of Isotopes, 7th ed. (Wiley, New York, 1978).
38. 251 seeds," Med. Phys. 15, 686-694 (1988).